BioRN is a life science research and industry cluster dedicated to the development of cell-specific, molecular and personalised innovative treatments and to the promotion of the region into one of the leading life science clusters in Europe.
Our network association consists of about 100 members.
Our members include:
- about 80 small and medium enterprises (SMEs);
- renowned research institutions such as the University of Heidelberg, the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), Mannheim University of applied science, University of Kaiserslautern (TU), Karlsruhe Institute of Technology (KIT), Fraunhofer IGB;
- global pharma companies such as AbbVie, Boehringer Ingelheim, Cellzome (a GSK company), Janssen Cilag (a Johnson&Johnson company), Merck, Roche and Sanofi-Aventis;
- local authorities, such as the City of Heidelberg, Mannheim and Ludwigshafen.
Beyond the members registered in the cluster, BioRN gives access to a wider network via partnerships and collaborations.
As a strong network, BioRN promotes cooperation between companies, authorities and universities and works as facilitator between institutions performing basic or applied research, between global pharma companies and SMEs or start-ups.
BioRN plans to strength its visibility and role on national and international level, with the objective to become one of the leading health clusters in Europe. Within this scope, BioRN recently intensified the collaboration with the Ci3 cluster in Mainz and acquired new members in the Frankfurt area. As part of its internationalisation strategy, BioRN funded in 2011 the Health Axis Europe (HAE) involving the health ecosystems of Leuven (Belgium), Maastricht (The Netherlands) and Copenhagen (Denmark).